Cite
HARVARD Citation
Augustyn, A. et al. (2021). The impact of cell-of-origin, MYC/Bcl-2 dual expression and MYC rearrangement on disease relapse among early stage diffuse large B-cell lymphoma patients treated with combined modality therapy. Leukemia & lymphoma. 62 (6), pp. 1361-1369. [Online].